Hutchmed Is Turning Profitable [Seeking Alpha]
HUTCHMED (China) Limited - American Depositary Shares (HCM)
NASDAQ:AMEX Investor Relations:
chi-med.com/investors/information-for-shareholders
Company Research
Source: Seeking Alpha
HCM's total revenue doubled to $838 million in 2023, driven by sales of the cancer drug FRUZAQLA. The company delivered a profit of $100.8 million in 2023 and has a strong cash position of over $880 million. FDA approval at the end of last year, and hopefully similar approvals from the EU and Japan will be a gamechanger for HCM. Investment Thesis When we started to cover HUTCHMED (China) Limited ( NASDAQ: HCM ) back in February of 2023, it was based on our interest to diversify our portfolio with the inclusion of shares in a pharmaceutical, medical, or healthcare company. Our introduction to HCM came all through our interest in CK Hutchison Holdings in Hong Kong ( OTCPK:CKHUY ), the conglomerate that holds about 38% of the shares in HCM. Just as a reminder, HCM is a small but global biopharmaceutical company developing high-quality, novel oncology and immunology drug candidates for patients across the world. Their market capitalization is about $3 billion. In our previo
Show less
Read more
Impact Snapshot
Event Time:
HCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HCM alerts
High impacting HUTCHMED (China) Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
HCM
News
- HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung CancerGlobeNewswire
- HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China [Yahoo! Finance]Yahoo! Finance
- HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in ChinaGlobeNewswire
- HUTCHMED to Host Expert Call to discuss Immune Thrombocytopenia [Yahoo! Finance]Yahoo! Finance
- HUTCHMED to Host Expert Call to discuss Immune ThrombocytopeniaGlobeNewswire
HCM
Sec Filings
- 9/9/24 - Form 6-K
- 8/30/24 - Form 6-K
- 8/22/24 - Form 6-K
- HCM's page on the SEC website